Report Detail
Global Opioid Induced Constipation (OIC) Drugs Market Insights, Forecast to 2025
- RnM3283146 |
- 08 April, 2019 |
- Global |
- 129 Pages |
- QYResearch |
- Pharma & Healthcare
The global Opioid Induced Constipation (OIC) Drugs market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Opioid Induced Constipation (OIC) Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Opioid Induced Constipation (OIC) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Opioid Induced Constipation (OIC) Drugs in these regions.
This research report categorizes the global Opioid Induced Constipation (OIC) Drugs market by top players/brands, region, type and end user. This report also studies the global Opioid Induced Constipation (OIC) Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Market size by Product
By Drug Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
By Prescription Type
Generic and Branded Prescribed Drugs
Over The Counter Drugs
Market size by End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Opioid Induced Constipation (OIC) Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Opioid Induced Constipation (OIC) Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Opioid Induced Constipation (OIC) Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Opioid Induced Constipation (OIC) Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Opioid Induced Constipation (OIC) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Opioid Induced Constipation (OIC) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Opioid Induced Constipation (OIC) Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by Product
- 1.4.2 Lubiprostone
- 1.4.3 Methyl Naltrexone Bromide
- 1.4.4 Naldemedine
- 1.4.5 Alvimopan
- 1.4.6 Other
- 1.5 Market by End User
- 1.5.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by End User
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Opioid Induced Constipation (OIC) Drugs Market Size
- 2.1.1 Global Opioid Induced Constipation (OIC) Drugs Revenue 2014-2025
- 2.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales 2014-2025
- 2.2 Opioid Induced Constipation (OIC) Drugs Growth Rate by Regions
- 2.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Regions
- 2.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Opioid Induced Constipation (OIC) Drugs Sales by Manufacturers
- 3.1.1 Opioid Induced Constipation (OIC) Drugs Sales by Manufacturers
- 3.1.2 Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Opioid Induced Constipation (OIC) Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturers
- 3.2.1 Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Opioid Induced Constipation (OIC) Drugs Price by Manufacturers
- 3.4 Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Opioid Induced Constipation (OIC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Product
- 4.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Product
- 4.3 Opioid Induced Constipation (OIC) Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Opioid Induced Constipation (OIC) Drugs Breakdown Data by End User
6 North America
- 6.1 North America Opioid Induced Constipation (OIC) Drugs by Countries
- 6.1.1 North America Opioid Induced Constipation (OIC) Drugs Sales by Countries
- 6.1.2 North America Opioid Induced Constipation (OIC) Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Opioid Induced Constipation (OIC) Drugs by Product
- 6.3 North America Opioid Induced Constipation (OIC) Drugs by End User
7 Europe
- 7.1 Europe Opioid Induced Constipation (OIC) Drugs by Countries
- 7.1.1 Europe Opioid Induced Constipation (OIC) Drugs Sales by Countries
- 7.1.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Opioid Induced Constipation (OIC) Drugs by Product
- 7.3 Europe Opioid Induced Constipation (OIC) Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs by Countries
- 8.1.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Countries
- 8.1.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs by Product
- 8.3 Asia Pacific Opioid Induced Constipation (OIC) Drugs by End User
9 Central & South America
- 9.1 Central & South America Opioid Induced Constipation (OIC) Drugs by Countries
- 9.1.1 Central & South America Opioid Induced Constipation (OIC) Drugs Sales by Countries
- 9.1.2 Central & South America Opioid Induced Constipation (OIC) Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Opioid Induced Constipation (OIC) Drugs by Product
- 9.3 Central & South America Opioid Induced Constipation (OIC) Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs by Countries
- 10.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Countries
- 10.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs by Product
- 10.3 Middle East and Africa Opioid Induced Constipation (OIC) Drugs by End User
11 Company Profiles
- 11.1 Ironwood Pharmaceuticals Inc
- 11.1.1 Ironwood Pharmaceuticals Inc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.1.5 Ironwood Pharmaceuticals Inc Recent Development
- 11.2 Daiichi Sankyo Co Ltd
- 11.2.1 Daiichi Sankyo Co Ltd Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.2.5 Daiichi Sankyo Co Ltd Recent Development
- 11.3 Pfizer
- 11.3.1 Pfizer Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.3.5 Pfizer Recent Development
- 11.4 Progenics Pharmaceuticals Inc
- 11.4.1 Progenics Pharmaceuticals Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.4.5 Progenics Pharmaceuticals Inc Recent Development
- 11.5 Shionogi & Co., Ltd
- 11.5.1 Shionogi & Co., Ltd Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.5.5 Shionogi & Co., Ltd Recent Development
- 11.6 Allergan Plc
- 11.6.1 Allergan Plc Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.6.5 Allergan Plc Recent Development
- 11.7 Nektar Therapeutics
- 11.7.1 Nektar Therapeutics Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.7.5 Nektar Therapeutics Recent Development
- 11.8 Purdue Pharma
- 11.8.1 Purdue Pharma Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.8.5 Purdue Pharma Recent Development
- 11.9 S.L.A. Pharma AG
- 11.9.1 S.L.A. Pharma AG Company Details
- 11.9.2 Company Business Overview
- 11.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.9.5 S.L.A. Pharma AG Recent Development
- 11.10 Mundipharma International Limited
- 11.10.1 Mundipharma International Limited Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.10.5 Mundipharma International Limited Recent Development
- 11.11 Ono Pharmaceutical Co., Ltd
- 11.12 Takeda Pharmaceutical Company Limited
- 11.13 Theravance Biopharma Inc
- 11.14 Valeant Pharmaceuticals International
- 11.15 Cosmo Pharmaceuticals SA
- 11.16 Daewoong Pharmaceutical
- 11.17 C.B. Fleet Company
- 11.18 Sucampo Pharmaceuticals
12 Future Forecast
- 12.1 Opioid Induced Constipation (OIC) Drugs Market Forecast by Regions
- 12.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Opioid Induced Constipation (OIC) Drugs Market Forecast by Product
- 12.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Product 2019-2025
- 12.3 Opioid Induced Constipation (OIC) Drugs Market Forecast by End User
- 12.4 North America Opioid Induced Constipation (OIC) Drugs Forecast
- 12.5 Europe Opioid Induced Constipation (OIC) Drugs Forecast
- 12.6 Asia Pacific Opioid Induced Constipation (OIC) Drugs Forecast
- 12.7 Central & South America Opioid Induced Constipation (OIC) Drugs Forecast
- 12.8 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Opioid Induced Constipation (OIC) Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Opioid Induced Constipation (OIC) Drugs . Industry analysis & Market Report on Opioid Induced Constipation (OIC) Drugs is a syndicated market report, published as Global Opioid Induced Constipation (OIC) Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Opioid Induced Constipation (OIC) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
